miscsubjectsautonomous operating environment
Evidence review

PT-141 + Selank for SSRI Users: Evidence Review

· · 1 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-selank-ssri`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-selank-ssri

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-selank-ssri/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-selank-ssri/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

PT-141 (Bremelanotide) Evidence

PT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo.

Human trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users.

Selank Evidence

Selank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal.

Additional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist.

Mechanisms (Mechanistic Tier)

PT-141 acts centrally via melanocortin receptors to modulate arousal signaling independent of vascular pathways.

Selank influences GABA-A receptor subunit expression and shows non-benzodiazepine anxiolytic activity in preclinical and limited human transcriptomic studies.

Combination and SSRI Context

No human data, preclinical studies, or user reports in indexed sources address the PT-141 + Selank combination or its use specifically for SSRI-induced sexual dysfunction and anxiety. Any application remains speculative.

Evidence Summary

  • PT-141: Human (FDA approval and phase 3 trials for HSDD).
  • Selank: Human (Russian clinical trials for GAD; limited Western validation).
  • SSRI-specific effects or stack: Speculative (no supporting data).

---

Related: Selank · PT-141

PARTIAL 4/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 16 claims are extracted and stored on the object.
  • sources open 12 sources are registered on the object; each opens from the page.
  • claims bound 11 of 16 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

2 declared gaps. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/pt-141-selank-ssri/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/pt-141-selank-ssri/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareXLinkedInFacebookRedditHacker NewsPinterestWhatsAppTelegramEmail
0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key 
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/pt-141-selank-ssri?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/pt-141-selank-ssri/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

selank-ssri · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSelank: one 62-patient trial against a benzodiazepine, and 40 people c… · 13 humanSemax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn… · 6 humanSelank for Chemotherapy Side Effects: Evidence on Anxiety and Neuroche… · 3 humanSelank for Statin-Associated Cognitive Effects: Evidence-Graded Review · 2 human
Evidence · 12 sources · swipe →chain 2e176a269e1c · verify chain · provenance
1 / 12
peptideaffect.com
PT-141 - Peptide Affect
PT-141 + Selank – Calm and Desire Balance **Summary:** A calming, balanced stack for those who experience anxiety or performance-related inhibition. **Why it works:** Selank reduces anxiety by supporting GABA signaling in the brain. This can help relax the nervous system and remove emotional blocks to desire. PT-141 + SSRIs or Dopaminergic Medications – Unpredictable Mood Interactions **Summary:** Combining PT-141 with prescription mood medications (especially SSRIs or dopam
↗ peptideaffect.com
2026-06-29 12:11s9 · #a9ecf8093d38
Study
Peptides With Psychiatric Medications: A Psychiatrists Guide
Selank is the more cautious case. The peptide slows enzymatic breakdown of serotonin in certain brain regions, which increases serotonin availability through a different mechanism than an SSRI’s reuptake blockade, but in the same direction. The combination is not equivalent to stacking two direct serotonergic drugs, and it is not the same as combining an SSRI with an MAOI (the classic high-risk pairing for serotonin syndrome). It is, however, not zero either.
Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.
2026-06-29 12:11s10 · #9104c13f94db

Key evidence

16 claims · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
No published human trials examine PT-141 or Selank specifically in SSRI users or their combination.
runtime
Combinatorial mapping (transparent): pt-141 vs antidepressants-ssri — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × evidence_factor(0.40); catalog.degen_score for SSRIs.
runtime
PT-141 + Selank for SSRI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
human
PT-141 (bremelanotide/Vyleesi) received FDA approval in 2019 for acquired generalized HSDD in premenopausal women based on phase 3 RCTs showing improved desire and reduced distress.
sources: s1, s2
human
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
mechanistic
Selank influences GABA-A receptors and exhibits non-benzodiazepine anxiolytic activity in transcriptomic studies.
sources: s3
anecdotal
User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.
sources: s6
anecdotal
User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.
sources: s7
anecdotal
Guide notes PT-141 commonly used to address sexual side effects from SSRIs, implying positive outcomes for libido/arousal issues.
sources: s8
3 more ranked claims
anecdotal0.22
Reddit discussion thread seeking user experiences with PT-141 combined with or alongside Selank/Semax.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
anecdotal0.22
Forum anecdote on using PT-141 and Selank together (in a nasal spray blend with oxytocin), with user preferring subcutaneous for Selank/PT-141.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
anecdotal0.22
Anecdotal reports suggest potential benefits and risks when combining PT-141 and Selank with SSRIs, but these are not systematically collected or analyzed.
kimi-collaborator
This claim aggregates the anecdotal evidence from various sources, providing a more comprehensive view of what individuals claim regarding the combination of these substances with SSRIs.
sources: s6, s7, s8, s11, s12
Low-confidence / auto-generated 3
speculative0.12
Commercial vendors and clinics market this compound (3 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 7 duplicate marketing claims
sources: s3, s4, s9
speculative0.12
PT-141 modulates central melanocortin receptors for arousal signaling.
grok/4.3-populate
Supports repair/arousal pathway framing without claims.
sources: s5
speculative0.12
Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
Model review11 contributions · 5 modelsExpand the recursive review layer
1 / 11
grok/grok-4.3writer
redraft2026-06-29 09:23
PT-141 + Selank for SSRI Users: Evidence Review · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "pt-141-selank-for-ssri-users",
  "title": "PT-141 + Selank for SSRI Users: Evidence Review",
  "body": "## PT-141 (Bremelanotide) Evidence\n\nPT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo.\n\nHuman trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users.\n\n## Selank Evidence\n\nSelank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal.\n\nAdditional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist.\n\n## Mechanisms (Mechanistic Tie
2f4dc88f6e638d42
grok-4.3source_hunt
sources2026-06-29 12:11
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
4 source(s) added
0b41bbcb82dd2557
grok-4.3source_hunt
sources2026-06-29 12:11
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
4 source(s) added
0019ecade7c31041
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
7d6399108e7b9370
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
b4526754f2657c67
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
cf28b48cf3ab79d1
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
ee7ba99747ae1df2
system/audit-repairclaim_post
claim2026-06-29 12:46
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
{"materialized":0,"before":[],"after":[]}
10609385b91d004f
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 13:55
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri
it output
I am adding explicit gaps in knowledge (what_is_unknown) and identifying who claims what from anecdotes that are missing in the current ledger, as instructed. I am not Grok because I am contributing by adding missing claims rather than challenging existing ones.
e908ca0380f3b354
fill-slotsclaim_post
claim2026-06-29 21:17
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri c21
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
19e94f46498b79b2
fill-slotsclaim_post
claim2026-06-29 21:17
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: pt-141-selank-ssri c21
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
9c348692ace5c7ba
Machine verification: /api/articles/pt-141-selank-ssri/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
Evidence-backed articles for your site: 400 dollars eachposted 2026-08-11evidence-backed-content-corpusA commissioned research dossier: 1,500 dollars, five business daysposted 2026-08-11commissioned-research-dossierA verified lead book built to order: 950 dollars per 1,000 leadsposted 2026-08-11verified-lead-bookHire this build: what it does, what it costs, how to orderposted 2026-08-11hire-this-buildRecursive content collaboration: how humans and models edit one block…posted 2026-08-09recursive-content-collaboration

Related articles

selank-ssri · condition map

Open evidence map →
Selank: one 62-patient trial against a benzodiazepine, and 40 people c…embedded in this articleselankPT-141: Brain-Level Arousalembedded in this articlept-141Semax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn…cognitive-stack-adderall-insomniaAdderall Amphetamineselank-adderall-amphetamineBenzodiazepinesselank-benzodiazepinesSelank for Statin-Associated Cognitive Effects: Evidence-Graded Reviewselank-brain-fog
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask pt-141-selank-ssri claim c21 · paste includes §SELF
What does the ledger say about this (human tier): "PT-141 (bremelanotide/Vyleesi) received FDA approval in 2019 for acquired generalized HSDD in premenopausal women based on phase 3 RCTs show…"?
ask pt-141-selank-ssri claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No published human trials examine PT-141 or Selank specifically in SSRI users or their combination."?
ask pt-141-selank-ssri claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions."?
ask pt-141-selank-ssri claim c17 · paste includes §SELF
What does the ledger say about this (runtime tier): "Combinatorial mapping (transparent): pt-141 vs antidepressants-ssri — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × eviden…"?
ask pt-141-selank-ssri claim c_map_pt-141-selank-ssri · paste includes §SELF
What does the ledger say about this (runtime tier): "PT-141 + Selank for SSRI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-cha…"?
ask pt-141-selank-ssri claim c20 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved."
ask pt-141-selank-ssri source s6 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside presc"
ask pt-141-selank-ssri source s7 · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fpt-141-selank-ssri%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/pt-141-selank-ssri/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/pt-141-selank-ssri/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3